10-K Filing

Astrana Health, Inc. CIK: 1083446 FY 2014

Filing Information

Form Type	10-K
Accession Number	`0001144204-15-042438`
Period End Date	20150331
Filing Date	20150714
Fiscal Year	2014
Fiscal Period	FY
XBRL Instance	ameh-20150331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 122 Income Statement 51 Cash Flow Statement 170 Stockholders Equity 36

Balance Sheet 122 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.01M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$6.83M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.45M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.18M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$1.51M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$3.80M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$1.51M	USD	Point-in-time
Common Stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other receivables	`AccountsAndOtherReceivablesNetCurrent`	$208.29K	USD	Point-in-time
Other receivables	`AccountsAndOtherReceivablesNetCurrent`	-	USD	Point-in-time
Other receivables	`AccountsAndOtherReceivablesNetCurrent`	-	USD	Point-in-time
Common Stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Due from Affiliates	`DueFromAffiliateCurrent`	$1.60K	USD	Point-in-time
Due from Affiliates	`DueFromAffiliateCurrent`	$36.40K	USD	Point-in-time
Due from Affiliates	`DueFromAffiliateCurrent`	$24.04K	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$53.54K	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	4.91M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$278.92K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$42.20K	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	4.86M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	4.70M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	4.70M	shares	Point-in-time
Deferred financing costs, net, current	`DeferredFinanceCostsCurrentNet`	$97.81K	USD	Point-in-time
Deferred financing costs, net, current	`DeferredFinanceCostsCurrentNet`	-	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	4.86M	shares	Point-in-time
Deferred financing costs, net, current	`DeferredFinanceCostsCurrentNet`	$513.65K	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	4.91M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$8.41M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$9.85M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$3.11M	USD	Point-in-time
Deferred financing costs, net, non-current	`DeferredFinanceCostsNoncurrentNet`	$144.34K	USD	Point-in-time
Deferred financing costs, net, non-current	`DeferredFinanceCostsNoncurrentNet`	$366.29K	USD	Point-in-time
Deferred financing costs, net, non-current	`DeferredFinanceCostsNoncurrentNet`	$264.71K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$582.47K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$85.69K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$94.95K	USD	Point-in-time
Restricted cash	`RestrictedCashAndInvestmentsCurrent`	$20.00K	USD	Point-in-time
Restricted cash	`RestrictedCashAndInvestmentsCurrent`	$20.00K	USD	Point-in-time
Restricted cash	`RestrictedCashAndInvestmentsCurrent`	$530.00K	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$59.63K	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$62.43K	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$1.38M	USD	Point-in-time
Goodwill	`Goodwill`	$494.70K	USD	Point-in-time
Goodwill	`Goodwill`	$2.17M	USD	Point-in-time
Goodwill	`Goodwill`	$494.70K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$218.72K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$41.64K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$38.68K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$15.00M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$9.48M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$3.96M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$1.44M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$3.35M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$1.09M	USD	Point-in-time
Medical liabilities	`MedicalLiabilitiesCurrent`	$552.56K	USD	Point-in-time
Medical liabilities	`MedicalLiabilitiesCurrent`	$1.26M	USD	Point-in-time
Medical liabilities	`MedicalLiabilitiesCurrent`	$285.62K	USD	Point-in-time
Notes and lines of credit payable, net of discount, current portion	`NotesAndLinesOfCreditPayableCurrent`	$327.14K	USD	Point-in-time
Notes and lines of credit payable, net of discount, current portion	`NotesAndLinesOfCreditPayableCurrent`	$322.23K	USD	Point-in-time
Notes and lines of credit payable, net of discount, current portion	`NotesAndLinesOfCreditPayableCurrent`	$3.18M	USD	Point-in-time
Convertible notes payable, net of discount, current portion	`ConvertibleNotesPayableCurrent`	-	USD	Point-in-time
Convertible notes payable, net of discount, current portion	`ConvertibleNotesPayableCurrent`	$1.04M	USD	Point-in-time
Convertible notes payable, net of discount, current portion	`ConvertibleNotesPayableCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.55M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.32M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.98M	USD	Point-in-time
Notes and lines of credit payable, net of discount, non-current portion	`LongTermNotesPayable`	-	USD	Point-in-time
Notes and lines of credit payable, net of discount, non-current portion	`LongTermNotesPayable`	$5.47M	USD	Point-in-time
Notes and lines of credit payable, net of discount, non-current portion	`LongTermNotesPayable`	$6.23M	USD	Point-in-time
Convertible notes payable, net of discount, non-current portion	`ConvertibleLongTermNotesPayable`	$962.98K	USD	Point-in-time
Convertible notes payable, net of discount, non-current portion	`ConvertibleLongTermNotesPayable`	$1.10M	USD	Point-in-time
Convertible notes payable, net of discount, non-current portion	`ConvertibleLongTermNotesPayable`	$1.46M	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesNoncurrent`	$2.35M	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesNoncurrent`	-	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesNoncurrent`	$2.14M	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilities`	-	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilities`	$171.22K	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilities`	$4.95K	USD	Point-in-time
Total liabilities	`Liabilities`	$5.65M	USD	Point-in-time
Total liabilities	`Liabilities`	$11.11M	USD	Point-in-time
Total liabilities	`Liabilities`	$15.99M	USD	Point-in-time
COMMITMENTS, CONTINGENCIES and SUBSEQUENT EVENTS (Notes 10 and 11 )	`CommitmentsAndContingencies`	-	USD	Point-in-time
COMMITMENTS, CONTINGENCIES and SUBSEQUENT EVENTS (Notes 10 and 11 )	`CommitmentsAndContingencies`	-	USD	Point-in-time
COMMITMENTS, CONTINGENCIES and SUBSEQUENT EVENTS (Notes 10 and 11 )	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, par value $0.001; 5,000,000 shares authorized; none issued	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.001; 5,000,000 shares authorized; none issued	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.001; 5,000,000 shares authorized; none issued	`PreferredStockValue`	-	USD	Point-in-time
Common Stock, par value $0.001; 100,000,000 shares authorized, 4,863,389, 4,913,455 and 4,695,247 shares issued and outstanding as of March 31, 2015, March 31, 2014 and January 31, 2014, respectively	`CommonStockValue`	$4.86K	USD	Point-in-time
Common Stock, par value $0.001; 100,000,000 shares authorized, 4,863,389, 4,913,455 and 4,695,247 shares issued and outstanding as of March 31, 2015, March 31, 2014 and January 31, 2014, respectively	`CommonStockValue`	$4.70K	USD	Point-in-time
Common Stock, par value $0.001; 100,000,000 shares authorized, 4,863,389, 4,913,455 and 4,695,247 shares issued and outstanding as of March 31, 2015, March 31, 2014 and January 31, 2014, respectively	`CommonStockValue`	$4.91K	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapital`	$16.52M	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapital`	$14.15M	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapital`	$15.13M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-16.77M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-17.54M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-19.34M	USD	Point-in-time
Stockholders' deficit attributable to Apollo Medical Holdings, Inc.	`StockholdersEquity`	$-2.82M	USD	Point-in-time
Stockholders' deficit attributable to Apollo Medical Holdings, Inc.	`StockholdersEquity`	$-2.62M	USD	Point-in-time
Stockholders' deficit attributable to Apollo Medical Holdings, Inc.	`StockholdersEquity`	$-2.41M	USD	Point-in-time
Non-controlling interests	`MinorityInterest`	$926.43K	USD	Point-in-time
Non-controlling interests	`MinorityInterest`	$1.83M	USD	Point-in-time
Non-controlling interests	`MinorityInterest`	$782.26K	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.69M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-990.18K	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-391.38K	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.62M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	`LiabilitiesAndStockholdersEquity`	$9.48M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	`LiabilitiesAndStockholdersEquity`	$15.00M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	`LiabilitiesAndStockholdersEquity`	$3.96M	USD	Point-in-time

Income Statement 51 line items

Line Item	Tag	Value	Unit	Period
Net revenues	`Revenues`	$32.99M	USD	Annual
Net revenues	`Revenues`	$2.34M	USD	1 Quarter
Net revenues	`Revenues`	$10.48M	USD	Annual
Cost of services	`CostOfServices`	$9.08M	USD	Annual
Cost of services	`CostOfServices`	$22.07M	USD	Annual
Cost of services	`CostOfServices`	$2.05M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$11.28M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$826.87K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$5.29M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$31.36K	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$5.76K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$334.43K	USD	Annual
Total costs and expenses	`OperatingExpenses`	$2.88M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$14.39M	USD	Annual
Total costs and expenses	`OperatingExpenses`	$33.68M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-694.33K	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-3.91M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-547.03K	USD	1 Quarter
Interest expense	`InterestExpense`	$184.58K	USD	1 Quarter
Interest expense	`InterestExpense`	$679.18K	USD	Annual
Interest expense	`InterestExpense`	$1.33M	USD	Annual
Gain on change in fair value of warrant and conversion feature liabilities	`GainLossOnDerivativeInstrumentsNetPretax`	$833.54K	USD	Annual
Gain on change in fair value of warrant and conversion feature liabilities	`GainLossOnDerivativeInstrumentsNetPretax`	-	USD	Annual
Gain on change in fair value of warrant and conversion feature liabilities	`GainLossOnDerivativeInstrumentsNetPretax`	-	USD	1 Quarter
Other	`OtherNonoperatingIncomeExpense`	$49.70K	USD	Annual
Other	`OtherNonoperatingIncomeExpense`	$28.82K	USD	1 Quarter
Other	`OtherNonoperatingIncomeExpense`	$3.03K	USD	Annual
Total other expense	`NonoperatingIncomeExpense`	$-629.48K	USD	Annual
Total other expense	`NonoperatingIncomeExpense`	$-489.83K	USD	Annual
Total other expense	`NonoperatingIncomeExpense`	$-155.76K	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-702.79K	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-1.18M	USD	Annual
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-4.54M	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	$7.82K	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$19.51K	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	$163.79K	USD	Annual
Net loss	`ProfitLoss`	$-4.56M	USD	Annual
Net loss	`ProfitLoss`	$-1.35M	USD	Annual
Net loss	`ProfitLoss`	$-710.61K	USD	1 Quarter
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$55.83K	USD	1 Quarter
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$454.64K	USD	Annual
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$461.42K	USD	Annual
Net loss attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$-1.80M	USD	Annual
Net loss attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$-5.02M	USD	Annual
Net loss attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$-766.44K	USD	1 Quarter
BASIC AND DILUTED	`EarningsPerShareBasicAndDiluted`	$-0.37	USD	Annual
BASIC AND DILUTED	`EarningsPerShareBasicAndDiluted`	$-1.37	USD	Annual
BASIC AND DILUTED	`EarningsPerShareBasicAndDiluted`	$-0.16	USD	1 Quarter
BASIC AND DILUTED	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	4.89M	shares	Annual
BASIC AND DILUTED	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	3.67M	shares	Annual
BASIC AND DILUTED	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	4.72M	shares	1 Quarter

Cash Flow Statement 170 line items

Line Item	Tag	Value	Unit	Period
Acquisitions, net of cash acquired	`CashAcquiredFromAcquisition`	$660.89K	USD	1 Quarter
Acquisitions, net of cash acquired	`CashAcquiredFromAcquisition`	$660.89K	USD	Annual
Acquisitions, net of cash acquired	`CashAcquiredFromAcquisition`	$660.89K	USD	Annual
Net loss	`ProfitLoss`	$-4.56M	USD	Annual
Net loss	`ProfitLoss`	$-1.35M	USD	Annual
Net loss	`ProfitLoss`	$-710.61K	USD	1 Quarter
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	-	USD	Annual
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	-	USD	1 Quarter
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	$64.81K	USD	Annual
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$31.36K	USD	Annual
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$5.76K	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$334.43K	USD	Annual
Gain on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$24.78K	USD	Annual
Gain on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Gain on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$23.00K	USD	1 Quarter
Gain on sale of marketable securities	`MarketableSecuritiesGainLoss`	-	USD	Annual
Gain on sale of marketable securities	`MarketableSecuritiesGainLoss`	-	USD	1 Quarter
Gain on sale of marketable securities	`MarketableSecuritiesGainLoss`	$49.79K	USD	Annual
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$4.95K	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-51.92K	USD	Annual
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	-	USD	Annual
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$2.16M	USD	Annual
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$60.19K	USD	1 Quarter
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$1.26M	USD	Annual
Amortization of financing costs	`AdjustmentForAmortization`	$255.40K	USD	Annual
Amortization of financing costs	`AdjustmentForAmortization`	$25.96K	USD	1 Quarter
Amortization of financing costs	`AdjustmentForAmortization`	$121.58K	USD	Annual
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$19.41K	USD	1 Quarter
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$400.39K	USD	Annual
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$136.75K	USD	Annual
Change in fair value of warrant and conversion feature liability	`GainLossOnDerivativeInstrumentsNetPretax`	$833.54K	USD	Annual
Change in fair value of warrant and conversion feature liability	`GainLossOnDerivativeInstrumentsNetPretax`	-	USD	Annual
Change in fair value of warrant and conversion feature liability	`GainLossOnDerivativeInstrumentsNetPretax`	-	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$912.21K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-1.13K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-72.92K	USD	Annual
Other receivable	`IncreaseDecreaseInOtherReceivables`	-	USD	Annual
Other receivable	`IncreaseDecreaseInOtherReceivables`	-	USD	1 Quarter
Other receivable	`IncreaseDecreaseInOtherReceivables`	$188.24K	USD	Annual
Due from affiliates	`IncreaseDecreaseDueFromAffiliates`	$22.44K	USD	1 Quarter
Due from affiliates	`IncreaseDecreaseDueFromAffiliates`	$-4.05K	USD	Annual
Due from affiliates	`IncreaseDecreaseDueFromAffiliates`	$-55.36K	USD	Annual
Prepaid expenses and advances	`IncreaseDecreaseInPrepaidExpense`	$118.05K	USD	Annual
Prepaid expenses and advances	`IncreaseDecreaseInPrepaidExpense`	$-11.34K	USD	1 Quarter
Prepaid expenses and advances	`IncreaseDecreaseInPrepaidExpense`	$-19.08K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$106.51K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$2.95K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$27.70K	USD	Annual
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$455.74K	USD	Annual
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$851.28K	USD	Annual
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$621.36K	USD	1 Quarter
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	-	USD	1 Quarter
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	-	USD	Annual
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	$249.61K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-8.89K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-1.48M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-271.91K	USD	Annual
Acquisitions, net of $660,893 of cash and cash equivalents acquired during the year ended March 31, 2015	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$250.00K	USD	Annual
Acquisitions, net of $660,893 of cash and cash equivalents acquired during the year ended March 31, 2015	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	1 Quarter
Acquisitions, net of $660,893 of cash and cash equivalents acquired during the year ended March 31, 2015	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$3.36M	USD	Annual
Increase in cash on consolidation of variable interest entity	`CashIncreaseOnConsolidationOfVariableInterestEntity`	$271.39K	USD	Annual
Increase in cash on consolidation of variable interest entity	`CashIncreaseOnConsolidationOfVariableInterestEntity`	-	USD	1 Quarter
Increase in cash on consolidation of variable interest entity	`CashIncreaseOnConsolidationOfVariableInterestEntity`	-	USD	Annual
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$438.88K	USD	Annual
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	-	USD	Annual
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	-	USD	1 Quarter
Property and equipment acquired	`PaymentsToAcquirePropertyPlantAndEquipment`	$12.23K	USD	1 Quarter
Property and equipment acquired	`PaymentsToAcquirePropertyPlantAndEquipment`	$22.93K	USD	Annual
Property and equipment acquired	`PaymentsToAcquirePropertyPlantAndEquipment`	$44.51K	USD	Annual
Increase in restricted cash	`IncreaseInRestrictedCash`	-	USD	Annual
Increase in restricted cash	`IncreaseInRestrictedCash`	$510.00K	USD	Annual
Increase in restricted cash	`IncreaseInRestrictedCash`	-	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-3.20M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-12.23K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-272.93K	USD	Annual
Proceeds from issuance of convertible note payable	`ProceedsFromConvertibleDebt`	$220.00K	USD	Annual
Proceeds from issuance of convertible note payable	`ProceedsFromConvertibleDebt`	-	USD	1 Quarter
Proceeds from issuance of convertible note payable	`ProceedsFromConvertibleDebt`	$2.00M	USD	Annual
Proceeds from line of credit	`ProceedsFromLinesOfCredit`	$7.00M	USD	1 Quarter
Proceeds from line of credit	`ProceedsFromLinesOfCredit`	$1.00M	USD	Annual
Proceeds from line of credit	`ProceedsFromLinesOfCredit`	$2.81M	USD	Annual
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$730.00K	USD	Annual
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$2.00M	USD	1 Quarter
Principal payments on notes payable	`PrincipalPaymentsOnTermNotePayable`	$936.08K	USD	Annual
Principal payments on notes payable	`PrincipalPaymentsOnTermNotePayable`	$530.00K	USD	Annual
Principal payments on notes payable	`PrincipalPaymentsOnTermNotePayable`	-	USD	1 Quarter
Payment of line of credit payable	`RepaymentsOfLinesOfCredit`	-	USD	Annual
Payment of line of credit payable	`RepaymentsOfLinesOfCredit`	-	USD	Annual
Payment of line of credit payable	`RepaymentsOfLinesOfCredit`	$2.81M	USD	1 Quarter
Payment of medical clinic acquisition notes payable	`PaymentOfMedicalClinicAcquisitionNotesPayable`	$256.00K	USD	1 Quarter
Payment of medical clinic acquisition notes payable	`PaymentOfMedicalClinicAcquisitionNotesPayable`	-	USD	Annual
Payment of medical clinic acquisition notes payable	`PaymentOfMedicalClinicAcquisitionNotesPayable`	-	USD	Annual
Payments in connection with convertible note redemption	`RepaymentsOfOtherShortTermDebt`	$98.25K	USD	1 Quarter
Payments in connection with convertible note redemption	`RepaymentsOfOtherShortTermDebt`	$707.91K	USD	Annual
Payments in connection with convertible note redemption	`RepaymentsOfOtherShortTermDebt`	-	USD	Annual
Contributions by non-controlling interest	`ProceedsFromPaymentsToMinorityShareholders`	$725.28K	USD	Annual
Contributions by non-controlling interest	`ProceedsFromPaymentsToMinorityShareholders`	-	USD	1 Quarter
Contributions by non-controlling interest	`ProceedsFromPaymentsToMinorityShareholders`	-	USD	Annual
Distributions to non-controlling interest shareholder	`PaymentsToMinorityShareholders`	$600.00K	USD	Annual
Distributions to non-controlling interest shareholder	`PaymentsToMinorityShareholders`	$200.00K	USD	1 Quarter
Distributions to non-controlling interest shareholder	`PaymentsToMinorityShareholders`	$240.00K	USD	Annual
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$258.15K	USD	Annual
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$533.65K	USD	Annual
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$232.68K	USD	1 Quarter
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$500.00	USD	Annual
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	-	USD	1 Quarter
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	-	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$1.66M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$2.03M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$5.40M	USD	1 Quarter
NET (DECREASE) INCREASE IN CASH & CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$5.38M	USD	1 Quarter
NET (DECREASE) INCREASE IN CASH & CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$274.68K	USD	Annual
NET (DECREASE) INCREASE IN CASH & CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.82M	USD	Annual
CASH & CASH EQUIVALENTS, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$5.01M	USD	Point-in-time
CASH & CASH EQUIVALENTS, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$6.83M	USD	Point-in-time
CASH & CASH EQUIVALENTS, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$1.45M	USD	Point-in-time
CASH & CASH EQUIVALENTS, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$1.18M	USD	Point-in-time
CASH & CASH EQUIVALENTS, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$5.01M	USD	Point-in-time
CASH & CASH EQUIVALENTS, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$6.83M	USD	Point-in-time
CASH & CASH EQUIVALENTS, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$1.45M	USD	Point-in-time
CASH & CASH EQUIVALENTS, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$1.18M	USD	Point-in-time
Interest paid	`InterestPaid`	$247.47K	USD	Annual
Interest paid	`InterestPaid`	$84.72K	USD	1 Quarter
Interest paid	`InterestPaid`	$768.85K	USD	Annual
Income taxes paid	`IncomeTaxesPaid`	$32.20K	USD	Annual
Income taxes paid	`IncomeTaxesPaid`	$19.51K	USD	Annual
Income taxes paid	`IncomeTaxesPaid`	$3.82K	USD	1 Quarter
Convertible note warrant	`ConvertibleNoteWarrant`	-	USD	1 Quarter
Convertible note warrant	`ConvertibleNoteWarrant`	$487.62K	USD	Annual
Convertible note warrant	`ConvertibleNoteWarrant`	$50.94K	USD	Annual
Convertible note conversion feature	`DebtInstrumentConvertibleBeneficialConversionFeature`	-	USD	Annual
Convertible note conversion feature	`DebtInstrumentConvertibleBeneficialConversionFeature`	-	USD	1 Quarter
Convertible note conversion feature	`DebtInstrumentConvertibleBeneficialConversionFeature`	$578.15K	USD	Annual
Acquisition related warrant consideration	`OtherSignificantNoncashTransactionValueOfConsiderationGiven1`	-	USD	1 Quarter
Acquisition related warrant consideration	`OtherSignificantNoncashTransactionValueOfConsiderationGiven1`	-	USD	Annual
Acquisition related warrant consideration	`OtherSignificantNoncashTransactionValueOfConsiderationGiven1`	$132.00K	USD	Annual
Acquisition related consideration fair value of units issued by consolidated subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$274.15K	USD	Annual
Acquisition related consideration fair value of units issued by consolidated subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	-	USD	Annual
Acquisition related consideration fair value of units issued by consolidated subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	-	USD	1 Quarter
Acquisition related deferred tax liability	`NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1`	$218.18K	USD	Annual
Acquisition related deferred tax liability	`NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1`	-	USD	1 Quarter
Acquisition related deferred tax liability	`NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1`	-	USD	Annual
Pre-acquisition net equity of non-controlling interest in variable interest entity	`NoncontrollingInterestIncreaseFromBusinessCombination`	$191.15K	USD	Annual
Pre-acquisition net equity of non-controlling interest in variable interest entity	`NoncontrollingInterestIncreaseFromBusinessCombination`	-	USD	1 Quarter
Pre-acquisition net equity of non-controlling interest in variable interest entity	`NoncontrollingInterestIncreaseFromBusinessCombination`	-	USD	Annual
NNA term loan discount	`DiscountOnTermLoan`	-	USD	Annual
NNA term loan discount	`DiscountOnTermLoan`	$1.25M	USD	1 Quarter
NNA term loan discount	`DiscountOnTermLoan`	-	USD	Annual
Shares issued in connection with convertible notes redemption	`SharesIssuedInConnectionWithNotesRedemption`	$864.30K	USD	Annual
Shares issued in connection with convertible notes redemption	`SharesIssuedInConnectionWithNotesRedemption`	-	USD	Annual
Shares issued in connection with convertible notes redemption	`SharesIssuedInConnectionWithNotesRedemption`	$51.75K	USD	1 Quarter
Fair value of warrant liabilities	`FairValueOfWarrantLiabilities`	-	USD	Annual
Fair value of warrant liabilities	`FairValueOfWarrantLiabilities`	-	USD	Annual
Fair value of warrant liabilities	`FairValueOfWarrantLiabilities`	$2.35M	USD	1 Quarter
NNA shares issuance discount	`DiscountOnSharesIssuance`	$1.10M	USD	1 Quarter
NNA shares issuance discount	`DiscountOnSharesIssuance`	-	USD	Annual
NNA shares issuance discount	`DiscountOnSharesIssuance`	-	USD	Annual
Shares issuable and issued for deferred financing costs	`IssuanceOfCommonStockValueInPaymentOfFinancingCost`	-	USD	1 Quarter
Shares issuable and issued for deferred financing costs	`IssuanceOfCommonStockValueInPaymentOfFinancingCost`	-	USD	Annual
Shares issuable and issued for deferred financing costs	`IssuanceOfCommonStockValueInPaymentOfFinancingCost`	$45.00K	USD	Annual
Notes payable issued in connection with medical clinic acquisitions	`NotesIssued1`	-	USD	Annual
Notes payable issued in connection with medical clinic acquisitions	`NotesIssued1`	$299.90K	USD	Annual
Notes payable issued in connection with medical clinic acquisitions	`NotesIssued1`	-	USD	1 Quarter
Settlement of stock issuable liability with issuance of shares	`SettlementOfStockIssuableLiabilityWithIssuanceOfShares`	$159.33K	USD	Annual
Settlement of stock issuable liability with issuance of shares	`SettlementOfStockIssuableLiabilityWithIssuanceOfShares`	-	USD	Annual
Settlement of stock issuable liability with issuance of shares	`SettlementOfStockIssuableLiabilityWithIssuanceOfShares`	-	USD	1 Quarter
Fair value of embedded conversion feature reacquired in connection with convertible notes redemption	`ConversionOfLineOfCreditToNotesPayable`	$509.89K	USD	Annual
Fair value of embedded conversion feature reacquired in connection with convertible notes redemption	`ConversionOfLineOfCreditToNotesPayable`	-	USD	1 Quarter
Fair value of embedded conversion feature reacquired in connection with convertible notes redemption	`ConversionOfLineOfCreditToNotesPayable`	-	USD	Annual

Stockholders Equity 36 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.69M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-990.18K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-391.38K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.62M	USD	Point-in-time
Net income (loss)	`ProfitLoss`	$-4.56M	USD	Annual
Net income (loss)	`ProfitLoss`	$-1.35M	USD	Annual
Net income (loss)	`ProfitLoss`	$-710.61K	USD	1 Quarter
Issuance of warrants	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$50.94K	USD	Annual
Issuance of warrants	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$132.00K	USD	Annual
Issuance of common stock for loan fees	`StockIssuedDuringPeriodValueOther`	$45.00K	USD	Annual
Issuance of stock for stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$730.98K	USD	Annual
Unvested stock-based compensation	`AdjustmentToAdditionalPaidInCapitalShareBasedCompensationNonVestedSharesRequisiteServicePeriodRecognition`	$333.84K	USD	Annual
Issuance of stock options for stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$1.25M	USD	Annual
Shares issued in connection with private placement offering	`StockIssuedDuringPeriodValueNewIssues`	$730.00K	USD	Annual
Shares issued in connection with convertible notes redemption	`DebtConversionConvertedInstrumentAmount1`	$864.30K	USD	Annual
Fair value of embedded conversion feature reacquired in connection with convertible notes redemption	`AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature`	$509.89K	USD	Annual
Contributions by non-controlling interest	`NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest`	$725.28K	USD	Annual
Shares issued in NNA financing	`StockIssuedDuringPeriodValueForFinancing`	$868.24K	USD	1 Quarter
8% notes share conversion	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$51.75K	USD	1 Quarter
Distributions to non-controlling interest shareholder	`MinorityInterestPeriodIncreaseDecrease`	$-600.00K	USD	Annual
Distributions to non-controlling interest shareholder	`MinorityInterestPeriodIncreaseDecrease`	$-240.00K	USD	Annual
Distributions to non-controlling interest shareholder	`MinorityInterestPeriodIncreaseDecrease`	$-200.00K	USD	1 Quarter
Issuance of membership interest in subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$274.15K	USD	Annual
Issuance of membership interest in subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	-	USD	Annual
Issuance of membership interest in subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	-	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$60.19K	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.26M	USD	Annual
Pre-acquisition net equity of non-controlling interest in variable interest entity	`NoncontrollingInterestIncreaseFromBusinessCombination`	$191.15K	USD	Annual
Pre-acquisition net equity of non-controlling interest in variable interest entity	`NoncontrollingInterestIncreaseFromBusinessCombination`	-	USD	1 Quarter
Pre-acquisition net equity of non-controlling interest in variable interest entity	`NoncontrollingInterestIncreaseFromBusinessCombination`	-	USD	Annual
Repurchase of common stock	`StockRepurchasedDuringPeriodValue`	$500.00	USD	Annual
Partial shares paid out in connection with 1 for 10 reverse stock split	`PartialValueOfSharesPaidOutInConnectionWithReverseStockSplit`	-	USD	Annual
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.69M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-990.18K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-391.38K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.62M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.